Women with osteoporosis (brittle bones) have two effective treatment choices: Prolia (denosumab) and Reclast (zoledronic acid). So which is more effective? A recent study did a side-by-side comparison.

When breast cancer spreads to the bones, various drugs are available to control the disease. This class of drugs is called biophosphonates . A manufacturer-funded study suggests its drug is better than others.